Pyogenic Vertebral Osteomyelitis clinical trials

Explore recruiting pyogenic vertebral osteomyelitis clinical trials.

Also recruiting in Europe

Pyogenic Vertebral Osteomyelitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO)

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Pyogenic Vertebral Osteomyelitis trials by city

Pyogenic Vertebral Osteomyelitis in Toronto Pyogenic Vertebral Osteomyelitis in Vancouver Pyogenic Vertebral Osteomyelitis in Montreal Pyogenic Vertebral Osteomyelitis in Calgary Pyogenic Vertebral Osteomyelitis in Edmonton Pyogenic Vertebral Osteomyelitis in Ottawa Pyogenic Vertebral Osteomyelitis in Winnipeg Pyogenic Vertebral Osteomyelitis in Quebec City Pyogenic Vertebral Osteomyelitis in Hamilton Pyogenic Vertebral Osteomyelitis in Kitchener Pyogenic Vertebral Osteomyelitis in London Pyogenic Vertebral Osteomyelitis in Halifax Pyogenic Vertebral Osteomyelitis in New York Pyogenic Vertebral Osteomyelitis in Los Angeles Pyogenic Vertebral Osteomyelitis in Chicago Pyogenic Vertebral Osteomyelitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease